Table 6.
Variable | AORc | 95 % CId | P value |
---|---|---|---|
Sex | |||
Female (versus male) | 0.44 | 0.86–6.24 | 0.09 |
CYP2B6 A785G (*4) | |||
A/G, G/G (versus A/A) | 1.74 | 0.89–3.46 | 0.10 |
ABCB1 G2677T/A | |||
G/T, T/T (versus G/G) | 0.48 | 0.23–1.01 | 0.05 |
Psychiatric disordersb | 2.71 | 1.10–6.53 | 0.02* |
Alcohol use history | 2.25 | 1.12–4.59 | 0.02* |
HCV | 6.42 | 1.14–121.3 | 0.03* |
aAge, marital status, tobacco use, betel nut use, current amphetamine use, treatment duration, HBV, pain disorders, depression, anxiety, methadone maintenance dose, CYP2B6 G516T, CYP2C19 G681A/C, G636A, C3402T, ABCB1 C1236T, and C3435T were not significantly associated. In the multiple logistic regression model, variables were selected using mixed stepwise regression; P value for model: 0.0002.
bPsychiatric disorders included schizophrenic disorders, hallucinosis, paranoia, panic disorders, and neurotic disorders.
cAOR, adjusted odds ratio.
d95% CI, 95% confidence interval.